Literature DB >> 18309469

[Chronic kidney disease and the cardiovascular system].

J Mann1, K F Hilgers, R Veelken, C Lenhardt, E L Schiffrin.   

Abstract

Depending on the reduction in glomerular filtration rate (GFR) as a measure of renal insufficiency and depending on their age, patients with chronic kidney disease have a 1.5 to 1,000-fold higher cardiovascular risk. Renal insufficiency is inherently an independent risk factor for cardiovascular events, which is likewise the case for patients also presenting with hypertension or diabetes mellitus. When cardiac insufficiency or coronary heart disease is already manifest, the GFR is the most important predictive factor for the patients' further survival. Proteinuria or albuminuria as signs of kidney disease are also important markers and correlate with the cardiovascular risk in the range of both macro- and microalbuminuria. Endothelial dysfunction, oxidative stress, dyslipidemia, and increased atherosclerosis are being discussed as pathophysiological mechanisms of elevated cardiovascular risk.

Entities:  

Mesh:

Year:  2008        PMID: 18309469     DOI: 10.1007/s00108-008-2092-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  22 in total

Review 1.  Endothelial dysfunction.

Authors:  Dierk H Endemann; Ernesto L Schiffrin
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

Review 2.  Statins for improving renal outcomes: a meta-analysis.

Authors:  Sabrina Sandhu; Natasha Wiebe; Linda F Fried; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2006-06-08       Impact factor: 10.121

3.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

4.  Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.

Authors:  Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Journal:  Hypertension       Date:  2005-01-17       Impact factor: 10.190

5.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Authors:  C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

6.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

Authors:  H L Hillege; A R Girbes; P J de Kam; F Boomsma; D de Zeeuw; A Charlesworth; J R Hampton; D J van Veldhuisen
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

7.  Microalbuminuria and coronary heart disease in NIDDM: an incidence study.

Authors:  M B Mattock; D J Barnes; G Viberti; H Keen; D Burt; J M Hughes; A P Fitzgerald; B Sandhu; P G Jackson
Journal:  Diabetes       Date:  1998-11       Impact factor: 9.461

8.  Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

Authors:  Michael G Shlipak; Paul A Heidenreich; Haruko Noguchi; Glenn M Chertow; Warren S Browner; Mark B McClellan
Journal:  Ann Intern Med       Date:  2002-10-01       Impact factor: 25.391

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Hypertension       Date:  2003-11       Impact factor: 10.190

10.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

Authors:  N B Shulman; C E Ford; W D Hall; M D Blaufox; D Simon; H G Langford; K A Schneider
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

View more
  1 in total

1.  Elevated atherogenic index and higher triglyceride increase risk of kidney function decline: a 7-year cohort study in Chinese adults.

Authors:  Fei Huang; Le Wang; Qian Zhang; Zhengce Wan; Liu Hu; Ranran Xu; Anying Cheng; Yongman Lv; Qingquan Liu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.